Skip to main content
. 2022 Oct 28;13:6453. doi: 10.1038/s41467-022-33834-4

Table 2.

Adverse events (AE) deemed possibly, probably, or certainly related to study drug graded according to Common Terminology Criteria for Adverse Events (CTCAE) 4.0

AE Grade 1 Grade 2 Grade ≥ 3 Any Grade
Injection site reaction 9 (43%) 6 (29%) 0 15 (71%)
Fever 2 (10%) 0 0 2 (10%)
Fatigue 1 (5%) 0 0 1 (5%)
Rash 1 (5%) 0 0 1 (5%)

Occurrence of adverse events are displayed as percentage of the 21 patients enroled in the study.